Niagen Bioscience (NAGE) Divestments (2013 - 2026)

Niagen Bioscience's (NAGE) quarterly Divestments came in at $5.8 million in Q1 2026, up 215.1% on a QoQ basis from $1.8 million in Q1 2015.

Niagen Bioscience (NAGE) Divestments (2013 - 2026) Analysis & Trends

Niagen Bioscience (NAGE) has 3 years of Divestments data on file, last reported at $5.8 million in Q1 2026.

On a quarterly basis, Divestments changed N/A year-over-year to $5.8 million in Q1 2026; TTM through Mar 2026 was $8.1 million, a N/A change from a year earlier, with the FY2015 full-year figure at $1.8 million, changed N/A from the prior year.
Divestments for Q1 2026 stood at $5.8 million, up from $1.8 million in the prior quarter.
Over the last five years, Divestments for NAGE reached as high as $5.8 million in Q1 2026 and fell as low as $5.8 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-32.58 Mn
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Niagen Bioscience	253.47 Mn	186.92 Mn	19.98 Mn	5.80 Mn

Download Data